pyrimidine has been researched along with Invasiveness, Neoplasm in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Allen, MD; Avril, N; Beltran, L; Bomalaski, JS; Chelala, C; Chmielewska-Kassassir, M; Crook, T; Cutts, R; Delage, B; Foster, J; Frezza, C; Ghazaly, E; Hudson, C; Jackson, RC; Jones, LJ; Lattanzio, L; Lemoine, NR; Leyton, J; Li, CF; Lo Nigro, C; Lu, YJ; Luong, P; Mather, S; Neal, D; Roylance, R; Sosabowski, J; Syed, N; Szlosarek, PW; Tomlinson, I; Warren, AY; Whitaker, HC; Wu, BW; Yuan, M | 1 |
1 other study(ies) available for pyrimidine and Invasiveness, Neoplasm
| Article | Year |
|---|---|
Prognostic and therapeutic impact of argininosuccinate synthetase 1 control in bladder cancer as monitored longitudinally by PET imaging.
Topics: Animals; Antimetabolites, Antineoplastic; Argininosuccinate Synthase; Cell Line, Tumor; Cell Proliferation; Disease Models, Animal; DNA Methylation; Drug Synergism; Female; Glutamates; Guanine; Humans; Hydrolases; Immunohistochemistry; Mice; Neoplasm Invasiveness; Pemetrexed; Polyethylene Glycols; Positron-Emission Tomography; Prognosis; Pyrimidines; Urinary Bladder Neoplasms; X-Ray Microtomography | 2014 |